1. Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials. Issue 10 (20th February 2013) Authors: Roustit, Matthieu; Blaise, Sophie; Allanore, Yannick; Carpentier, Patrick H; Caglayan, Evren; Cracowski, Jean-Luc Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 10(2013) Page Start: 1696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response to letter to editor regarding: "Risks and contraindications of medical compression treatment – a critical reappraisal. An international consensus statement PHLEB-19-150.R1". (December 2020) Authors: Rabe, Eberhard; Partsch, Hugo; Morrison, Nick; Meissner, Mark H; Mosti, Giovanni; Lattimer, Christopher R; Carpentier, Patrick H; Gaillard, Sylvain; Juenger, Michael; Urbanek, Tomasz; Hafner, Juerg; Patel, Malay; Wu, Stephanie; Caprini, Joseph; Lurie, Fedor; Hirsch, Tobias Journal: Phlebology Issue: Volume 35:Number 10(2020) Page Start: 838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement. (August 2020) Authors: Rabe, Eberhard; Partsch, Hugo; Morrison, Nick; Meissner, Mark H; Mosti, Giovanni; Lattimer, Christopher R; Carpentier, Patrick H; Gaillard, Sylvain; Jünger, Michael; Urbanek, Tomasz; Hafner, Juerg; Patel, Malay; Wu, Stephanie; Caprini, Joseph; Lurie, Fedor; Hirsch, Tobias Journal: Phlebology Issue: Volume 35:Number 7(2020) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗